At least week's inaugural Mansion House speech, new chancellor Rachel Reeves announced what she called 'the biggest set of reforms to the pensions market in decades' with the plan to merge local government pension schemes (LPGS) into a series of 'megafunds' along the lines of Australia's 'supers'.The plan is to pool the assets from 86 LGPS in England and Wales, reportedly managing £500 billion in

European equities traded higher on Wednesday morning, as stocks in London shrugged off a hotter-than-forecast UK inflation reading for now.Sage shone on the FTSE 100, while Severn Trent also impressed.The FTSE 100 index climbed 23.61 points, 0.3%, at 8,122.63. The FTSE 250 edged up 22.23 points, 0.1%, at 20,449.85, and the AIM All-Share was up 2.56 points, 0.4%, at 726.79.The Cboe UK 100 was up 0.

Stocks in London saw a mixed start to the week on Monday, as housebuilders and the property sector weighed on mid-caps, while rising commodity prices lifted large-caps.The FTSE 100 index rose 45.71 points, 0.6%, at 8,109.32. The FTSE 250 declined 81.23 points, 0.4%, at 20,395.41, and the AIM All-Share climbed 0.41 of a point, 0.1%, at 727.55.The Cboe UK 100 ended up 0.5% at 814.60, the Cboe UK 250

There was a certain degree of investor bemusement last month when shares in US electricity generation company Constellation Energy (CEG:NASDAQ) soared on news technology giant Microsoft (MSFT:NASDAQ) had signed a 20-year power purchase agreement.This was no ordinary deal, however, as it paves the way for the restart of Three Mile Island 1 ? not the reactor which famously melted down in 1979, but a

The FTSE 100 joined European peers in the red on Wednesday, while the US hit new highs following Donald Trump's win in the presidential election.The FTSE 100 index closed down 5.71 points, or 0.1%, at 8,166.68. It had earlier hit an intra-day high of 8,301.78.The FTSE 250 ended up 76.66 points, 0.4%, at 20,446.70, and the AIM All-Share rose 2.75 points, 0.3%, at 739.04.The Cboe UK 100 ended slight

Profits up 17.2%Tasty growth in foodInternational sales down 10.3%Marks & Spencer (MKS) reported a forecast-beating jump in half-year profits as the retail bellwether's turnaround continues to gain traction, sending shares in the FTSE 100 company up 8% to a five-year high of 414p.With its dependable food and revitalised clothing and home divisions both gobbling up market share and Marks & Spencer'

Just days after celebrating better-than-expected third-quarter net income and earnings, investors in Lloyds (LLOY) received a cold shower as the shares lost 10% of their value in response to a court ruling in a motor finance case.On 25 October, the Court of Appeal ruled in favour of three claimants against FirstRand Bank and Close Brothers (CBG) over the duty of motor dealers acting as credit brok

As Martin Gamble discusses in this issue, some businesses are awaiting the upcoming Budget on 30 October with real trepidation. However, an announcement from the Labour Government was cause for celebration with one smaller company when this author had the opportunity to meet with them in early October.Flow battery technology firm Invinity Energy Systems (IES:AIM) has had a tough little spell due t

Stock prices in London were in the red on Monday midday, ahead of a slew of inflationary prints coming this week, including consumer prices from the UK on Wednesday.The FTSE 100 index was down 7.70 points, or 0.1%, at 8,245.95. The FTSE 250 was down 55.44 points, or 0.3%, at 20,709.49, and the AIM All-Share was down 0.74 points, or 0.1%, at 733.11.The Cboe UK 100 was down 0.2% at 825.83, the Cboe

Stock prices rose on Monday morning in London despite reports of new restrictions on the UK gambling sector and disappointing data from China, ahead of US consumer inflation expectations.The FTSE 100 index opened up 5.62 points, or 0.1%, at 8,259.69. The FTSE 250 was up 8.14 points at 20,772.98, and the AIM All-Share was up 0.78 points, or 0.1%, at 734.63.The Cboe UK 100 was down slightly at 826.7

Stock prices in Europe were in the green on Thursday as investors awaited several US data prints and remarks from Fed Chair Jerome Powell.The People's Bank of China 'has 'thrown the proverbial kitchen sink at the economy', Pepperstone's Michael Brown said.'Fresh from big stimulus measures earlier in the week, all eyes remained focused on China amid talk that Beijing might inject up to ¥1 tril

The investment trust sector is in celebratory mood after the Labour government and the FCA (Financial Conduct Authority) announced (19 September) they will exempt London-listed investment trusts from the EU's PRIIPs (Packaged Retail and Insurance-based Investment Products regulation) and Mifid directives that forced them to double-count their costs.Onerous and misleading disclosure requirements ha

First half profits plungeFirst interim dividend in five yearsFull year guidance unchangedFollowing a stunning run into the numbers, shares in Card Factory (CARD) cheapened 16% to 121p after the value-focused greeting cards-to-party supplies retailer delivered a drop in first half earnings and warned full year profits will be second half weighted.While some investors took profits on the unnerving n

Equities in London opened in the red on Monday morning, as AstraZeneca released disappointing trial results while REA upped the ante with a sweetened takeover bid for fellow property portal Rightmove.Monday's economic diary has several flash composite purchasing managers' index releases including from the US and UK.The FTSE 100 index traded down 6.78 points, 0.1%, at 8,223.21. The FTSE 250 was dow

London's FTSE 100 index fell on Tuesday, amid share price falls for some of its largest constituents, including AstraZeneca, BP and Shell.The FTSE 100 index fell 64.86 points, or 0.8%, at 8,205.98. The FTSE 250 ended flat at 20,656.14, and the AIM All-Share eased 2.87 points, or 0.4%, at 743.86.5.The Cboe UK 100 slid 0.6% to 821.91, the Cboe UK 250 rose 0.1% at 18,185.65, and the Cboe Small Compan

Late-stage lung cancer trial disappointsTreatment was expected to be 'blockbuster'US regulatory approval now in doubtShares in pharmaceutical giant AstraZeneca (AZN), fell more than 5% to a one month low after the UK's largest quoted company released disappointing data from a late-stage clinical trial of its precision lung cancer drug Dato-DxD.The shares have been on a tear over the last six month

Blue chips traded lower at midday on Tuesday, pegged back by falls in several index heavyweights, in a mixed day for stocks in London.The FTSE 100 index traded down 43.48 points, 0.5%, at 8,227.36. The FTSE 250 was up 32.47 points, 0.2%, at 20,683.35, and the AIM All-Share was down 0.69 of a point, 0.1%, at 746.04.The Cboe UK 100 was down 0.4% at 823.76, the Cboe UK 250 rose 0.4% at 18,228.80, and

London's FTSE 100 fell in early trading on Tuesday, underperforming European peers, pegged back by a sharp fall in AstraZeneca shares.The FTSE 100 index traded down 27.30 points, 0.3%, at 8,243.54. The FTSE 250 was up 57.16 points, 0.3%, at 20,708.04, and the AIM All-Share was down 0.87 of a point, 0.1%, at 747.60.The Cboe UK 100 was down 0.2% at 824.77, the Cboe UK 250 rose 0.4% at 18,235.85, and

Half- and full-year guidance confirmedCore brands hold up in soft marketsSecond tranche of buyback starts todayShareholders in beer and cider producer C&C Group (CCR) celebrated a small win after the company confirmed its half-year profit forecast and continued its share buyback with a small but symbolic programme to buy €15 million (£12.7 million) of stock starting today.The shares rose 2%

Stocks in London were in the red during midday trade on Friday, with investors fixed on this afternoon's US nonfarm payrolls data.The FTSE 100 index was down 30.44 points, or 0.4%, at 8,211.04. The FTSE 250 was down 136.32 points, or 0.7%, at 20,626.66, and the AIM All-Share was down 11.51 points, or 1.5%, at 747.61.The Cboe UK 100 was down 0.5% at 821.21, the Cboe UK 250 was down 0.8% at 18,167.1